IMPROVE SPEED AND ACCURACY OF MONOCLONAL ANTIBODY BIOANALYSIS USING NANOTECHNOLOGY AND LCMS
Ostatní
| N/A | Shimadzu
LC/MS, LC/MS/MS, LC/QQQ
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Shimadzu
Zaměření
Klinická analýza
LCMS Bioanalysis of Antibody Drugs Using Fab-selective Proteolysis “nSMOL Method” — Selection of Signature Peptide —
Aplikace
| 2017 | Shimadzu
LC/MS, LC/MS/MS, LC/QQQ
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Shimadzu
Zaměření
Farmaceutická analýza
LC-MS/MS quantitative method development of Herceptin based on selective hydrolysis (nSMOL) technology and Skyline software
Postery
| 2017 | Shimadzu
Software, LC/MS, LC/MS/MS, LC/QQQ
Instrumentace
Software, LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Shimadzu
Zaměření
Klinická analýza
Bioanalytical assessment of Cetuximab in Wistar rat plasma using nSMOL and LCMS-8060
Aplikace
| 2011 | Shimadzu
LC/MS, LC/MS/MS, LC/QQQ
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Shimadzu
Zaměření
Klinická analýza
Qualitative Characterization and Quantitative Assessment of Monoclonal Antibodies Using Protein Metrics and nSMOLcoupled with the Shimadzu LCMS-9030 QTOF
Postery
| 2019 | Shimadzu
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Instrumentace
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Výrobce
Shimadzu
Zaměření
Klinická analýza
Pre-clinical estimation of cetuximab using nano-surface and molecular orientation limited (nSMOL) proteolysis and LC-MS/MS
Postery
| N/A | Shimadzu
LC/MS, LC/MS/MS, LC/QQQ
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Shimadzu
Zaměření
Klinická analýza
Affnity purifcation of IdeZ digest for Glycosylation profle of Immunoglobulins using a linear benchtop MALDI-TOFMS.
Postery
| 2019 | Shimadzu
MALDI, LC/TOF, LC/MS
Instrumentace
MALDI, LC/TOF, LC/MS
Výrobce
Shimadzu
Zaměření
Klinická analýza
Shimadzu Microow Liquid Chromatography Mass Spectrometry System Nexera Mikros
Brožury a specifikace
| 2020 | Shimadzu
HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/QQQ
Instrumentace
HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Shimadzu
Zaměření
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis -
Aplikace
| 2017 | Shimadzu
LC/MS, LC/MS/MS, LC/QQQ
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Shimadzu
Zaměření
Klinická analýza
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - Nivolumab analysis -